CA-125 SECRETION BY LUTEAL PHASE ENDOMETRIUM INVITRO

被引:16
作者
BRUMSTED, JR
MCBEAN, JH
DEATON, JL
GIBSON, M
机构
[1] Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, VT 05405
关键词
CA-125; Endomertrium; Luteal phase;
D O I
10.1093/oxfordjournals.humrep.a137167
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The source of CA-125 in normal women and the mechanisms which control CA-125 production remain to be defined. This study was initiated to examine the pattern of secretion of CA-125 from luteal phase endometrium. Endometrial samples were obtained during the early luteal phase (histological days 16-18) and late luteal phase (histological days 25-27) from ovulatory women with a laparoscopically normal pelvis. The tissue was maintained in explant culture using Trowell's T-8 medium with either no additions (NA), progesterone (P), oestradiol (E2), orE2 + P. The concentration of CA-125 in spent media from the second day in culture was determined by immunoradiometric assay. In early luteal endometrium, the concentration of CA-125 in spent media from the NA treated wells was significantly higher than when the endometrium was exposed to either P or E2 + P. Similar differences were noted between treatments for the late luteal endometrium. Within each treatment, there was a higher concentration of CA-125 in the spent media from the late versus the early luteal endometrium. We conclude that the endometrium is a potential source of serum CA-125 and that endometrial CA-125 is suppressed by P in both the early and the late luteal phase. Further, there appears to be an increase in endometrial CA-125 secretion from the early to the late luteal phase. © 1990 Oxford University Press.
引用
收藏
页码:682 / 684
页数:3
相关论文
共 8 条
[1]  
Bast R.C., Freeney M., Lazarus H., Nadler L.M., Colvin R.B., Knapp R.C., Reactivity of a monoclonal antibody with human ovarian carcinoma, J. Clin. Invest., 68, pp. 1331-1337, (1981)
[2]  
Bischoff P., Tseng L., Brioschi P.A., Herrman W.L., Cancer antigen 125 is produced by human endometrial stroma cells. Hum, Reprod., 7, pp. 423-426, (1986)
[3]  
Brumsted J.R., Nakajima S., Badger G., Riddick D.H., Gibson M., Serum concentrations of CA125 during the first trimester of normal and abnormal pregnancies, J. Reprod. Med., 35, pp. 499-502, (1989)
[4]  
Brumsted J.R., Chapitis J., Deaton J.L., Riddick D.H., Gibson M., Prostaglandin synthesis and metabolism in luteal phase endometrium in vitro. Fertil, Steril., 52, pp. 769-773, (1989)
[5]  
Jager W., Meier C., Wildt L., Sauerbrei W., Lang N., CA-125 serum concentrations during the menstrual cycle. Fertil, Steril., 50, pp. 223-227, (1988)
[6]  
Kabawat S.E., Bast R.C., Bhan A.K., Welch W.R., Knapp R.C., Colvin R.B., Tissue distribution of a coelomic-epithelium-relaled antigen recognized by the monoclonal antibody OC125, Int. J. Gynecol. Pathol., 2, pp. 275-285, (1983)
[7]  
Noyes R.W., Hertig A.T., Rock J., Dating the endometrial biopsy. Fértil, Steril., 1, pp. 3-25, (1950)
[8]  
Patton P.E., Field C.S., Harms R.W., Coulam C.B., CA-125 levels in endometriosis. Fertil, Steril., 45, pp. 770-773, (1986)